Stockscreener 앱 받기
44.21
13.83%
5.37
시간 외 거래:
44.22
0.010
+0.02%
전일 마감가:
$38.84
열려 있는:
$38.8
하루 거래량:
34,485
Relative Volume:
0.83
시가총액:
$272.77M
수익:
-
순이익/손실:
$-7.12M
주가수익비율:
-19.22
EPS:
-2.3
순현금흐름:
$-6.82M
1주 성능:
+29.46%
1개월 성능:
+9.30%
6개월 성능:
+43.54%
1년 성능:
+1,719%
1일 변동 폭
$38.66
$44.22
1주일 범위
$32.77
$44.22
52주 변동 폭
$2.2901
$54.30
Monopar Therapeutics Inc Stock (MNPR) Company Profile
명칭
Monopar Therapeutics Inc
전화
(847) 388-0349
주소
1000 SKOKIE BLVD SUITE 350, WILMETTE
MNPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
44.21 | 239.64M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 개시 | Oppenheimer | Outperform |
| 2025-09-03 | 개시 | Raymond James | Strong Buy |
| 2025-08-26 | 재개 | H.C. Wainwright | Buy |
| 2025-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-23 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-19 | 재개 | Piper Sandler | Overweight |
| 2025-01-10 | 개시 | Piper Sandler | Overweight |
| 2024-10-11 | 개시 | Rodman & Renshaw | Buy |
| 2021-01-28 | 개시 | ROTH Capital | Buy |
모두보기
Monopar Therapeutics Inc 주식(MNPR)의 최신 뉴스
Best data tools to analyze Monopar Therapeutics Inc. stock2025 Trade Ideas & Accurate Buy Signal Notifications - Newser
Evaluating Monopar Therapeutics Inc. with trendline analysisNew Guidance & Daily Price Action Insights - Newser
Monopar Therapeutics Inc. (NASDAQ:MNPR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Can Monopar Therapeutics Inc. weather a recessionTrade Entry Summary & Community Consensus Picks - خودرو بانک
Analyzing net buyer seller activity in Monopar Therapeutics Inc.Market Trend Report & Long-Term Capital Growth Ideas - Newser
Is Monopar Therapeutics Inc. stock showing strong momentumPortfolio Gains Summary & Weekly High Return Forecasts - خودرو بانک
How moving averages guide Monopar Therapeutics Inc. tradingMarket Volume Report & High Accuracy Trade Signal Alerts - Newser
How to escape a deep drawdown in Monopar Therapeutics Inc.2025 Trade Ideas & High Conviction Investment Ideas - Newser
What is the Moat Score of Monopar Therapeutics Inc.July 2025 Weekly Recap & Verified Trade Idea Suggestions - خودرو بانک
AlphaQuest LLC Makes New $44,000 Investment in Monopar Therapeutics Inc. $MNPR - Defense World
Using data models to predict Monopar Therapeutics Inc. stock movementMarket Sentiment Review & Weekly Hot Stock Watchlists - Newser
Is Monopar Therapeutics Inc. stock suitable for long term investing2025 EndofYear Setup & Short-Term Trading Alerts - خودرو بانک
Applying big data sentiment scoring on Monopar Therapeutics Inc.Portfolio Profit Report & Weekly Stock Performance Updates - Newser
Is Monopar Therapeutics Inc. currently under institutional pressureWeekly Trade Recap & High Conviction Buy Zone Picks - خودرو بانک
Monopar Therapeutics: A Speculative Buy On 2 Fronts With Catalysts Imminent (NASDAQ:MNPR) - Seeking Alpha
Is Monopar Therapeutics Inc.’s growth already priced inJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - خودرو بانک
Will Monopar Therapeutics Inc. bounce back from current supportWeekly Market Report & Low Volatility Stock Recommendations - Newser
Should you hold or exit Monopar Therapeutics Inc. nowLayoff News & AI Based Buy and Sell Signals - Newser
Visual analytics tools that track Monopar Therapeutics Inc. performanceWeekly Trade Review & Smart Investment Allocation Tips - Newser
Will Monopar Therapeutics Inc. outperform the marketGlobal Markets & Daily Technical Forecast Reports - Newser
Monopar a new outperform at Oppenheimer on Wilson disease candidate - Seeking Alpha
Will Monopar Therapeutics Inc. stock recover after earningsJuly 2025 Spike Watch & Weekly Watchlist of Top Performers - خودرو بانک
Monopar Announces Abstract Accepted with Distinction for Oral and Poster Presentations at the Upcoming American Neurological Association 2025 Annual Meeting - The Manila Times
Monopar's Wilson Disease Drug Study Selected for ANA 2025 Meeting | MNPR Stock News - Stock Titan
Raymond James Initiates Monopar Therapeutics at Strong Buy With $80 Price Target - MarketScreener
Detecting price anomalies in Monopar Therapeutics Inc. with AIQuarterly Profit Review & Reliable Price Action Trade Plans - Newser
Will Monopar Therapeutics Inc. see short term momentum2025 Technical Patterns & Long-Term Safe Investment Plans - Newser
Risk vs reward if holding onto Monopar Therapeutics Inc.Portfolio Growth Summary & Intraday High Probability Setup Alerts - Newser
Sentiment analysis tools applied to Monopar Therapeutics Inc2025 Risk Factors & Technical Buy Zone Confirmations - Newser
Sentiment analysis tools applied to Monopar Therapeutics Inc.July 2025 Trends & Real-Time Chart Breakout Alerts - Newser
What analysts say about Monopar Therapeutics Inc. stockMarket Growth Report & Entry and Exit Point Strategies - خودرو بانک
Real time pattern detection on Monopar Therapeutics Inc. stockPortfolio Growth Summary & High Accuracy Trade Alerts - Newser
Statistical indicators supporting Monopar Therapeutics Inc.’s strengthStop Loss & Daily Stock Trend Reports - Newser
Published on: 2025-09-02 23:38:23 - Newser
Visualizing Monopar Therapeutics Inc. stock with heatmaps2025 Bull vs Bear & Free Long-Term Investment Growth Plans - Newser
Published on: 2025-09-02 12:19:21 - Newser
Technical Charts Suggest Momentum Shift in Monopar Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Can Monopar Therapeutics Inc. outperform in the next rallyForecast Cut & Weekly Stock Breakout Alerts - خودرو بانک
Why Monopar Therapeutics Inc. is moving todayJuly 2025 Market Mood & Weekly Momentum Picks - Newser
Will Monopar Therapeutics Inc. price bounce be sustainableWeekly Trade Recap & High Return Trade Opportunity Guides - Newser
Is Monopar Therapeutics Inc. stock reversal real or fakeGap Up & Free Technical Confirmation Trade Alerts - Newser
Can machine learning forecast Monopar Therapeutics Inc. recoveryPortfolio Risk Report & Weekly High Potential Stock Alerts - Newser
Price Action Confirms Reversal in Monopar Therapeutics Inc. Trend getLinesFromResByArray error: size == 0 - kangso.co.kr
What’s the RSI of Monopar Therapeutics Inc. stockJuly 2025 Big Picture & AI Powered Market Trend Analysis - خودرو بانک
Monopar Therapeutics Inc. Reversal Rally May Surprise Bears getLinesFromResByArray error: size == 0 - 강소기업뉴스
Custom strategy builders for tracking Monopar Therapeutics Inc.CEO Change & AI Based Buy and Sell Signals - Newser
Monopar Therapeutics Inc (MNPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Monopar Therapeutics Inc 주식 (MNPR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| STARR CHRISTOPHER M | Director |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
5,173 |
| Robinson Chandler | Chief Executive Officer |
Jul 14 '25 |
Sale |
40.00 |
16,800 |
672,020 |
73,472 |
1.40%
자본화:
|
볼륨(24시간):